Sivik Global Healthcare LLC Has $2.87 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Sivik Global Healthcare LLC grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 40.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,000 shares of the company’s stock after purchasing an additional 10,000 shares during the period. Sivik Global Healthcare LLC’s holdings in GE HealthCare Technologies were worth $2,871,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of GEHC. Thoma Capital Management LLC grew its position in GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares in the last quarter. True North Advisors LLC grew its position in GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares in the last quarter. Klingman & Associates LLC grew its position in GE HealthCare Technologies by 4.0% during the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after purchasing an additional 139 shares in the last quarter. Colonial Trust Advisors grew its position in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares in the last quarter. Finally, Norinchukin Bank The grew its position in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.0%

GEHC opened at $69.73 on Wednesday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The business has a 50-day moving average of $76.48 and a 200-day moving average of $77.98. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company has a market capitalization of $31.82 billion, a PE ratio of 15.29, a price-to-earnings-growth ratio of 1.55 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Wall Street Analyst Weigh In

GEHC has been the topic of several research analyst reports. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Morgan Stanley raised their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. BTIG Research restated a “buy” rating and set a $91.00 price target on shares of GE HealthCare Technologies in a report on Thursday, March 19th. Jefferies Financial Group raised their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus target price of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.